UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Ethan Allen Interiors
ETD
$598M
| $9.93M | ﹤0.01% |
353,121
-141,853
| -29% | -$4.21M |
|
3052
MidCap Financial Investment
MFIC
$800M
| $9.92M | ﹤0.01% |
735,387
+296,055
| +67% | +$4.02M |
|
|
MAGN
3053
Magnera Corp
MAGN
$446M
| $9.92M | ﹤0.01% |
545,916
+544,993
| +59,046% | +$11.2M |
|
3054
TRI-Continental Corp
TY
$1.89B
| $9.9M | ﹤0.01% |
312,395
+56,431
| +22% | +$1.87M |
|
3055
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.35B
| $9.9M | ﹤0.01% |
103,598
-3,831
| -4% | -$379K |
|
3056
Southside Bancshares
SBSI
$974M
| $9.9M | ﹤0.01% |
311,687
+243,544
| +357% | +$8.27M |
|
3057
Reynolds Consumer Products
REYN
$5.54B
| $9.88M | ﹤0.01% |
365,950
+299,738
| +453% | +$8.5M |
|
3058
CALL
Generac Holdings
GNRC
$12.5B
| $9.86M | ﹤0.01% |
63,600
| – | – |
|
3059
QuidelOrtho
QDEL
$1.11B
| $9.86M | ﹤0.01% |
221,332
+157,025
| +244% | +$6.42M |
|
3060
Celldex Therapeutics
CLDX
$3.26B
| $9.85M | ﹤0.01% |
389,797
+223,200
| +134% | +$6.06M |
|
3061
ProShares Short QQQ
PSQ
$729M
| $9.85M | ﹤0.01% |
263,283
-26,002
| -9% | -$995K |
|
|
RMT
3062
Royce Micro-Cap Trust
RMT
$751M
| $9.84M | ﹤0.01% |
1,008,813
+12,587
| +1% | +$124K |
|
3063
UroGen Pharma
URGN
$2.22B
| $9.83M | ﹤0.01% |
922,698
+876,923
| +1,916% | +$10.5M |
|
3064
Nuveen ESG Mid-Cap Growth ETF
NUMG
$357M
| $9.82M | ﹤0.01% |
207,300
+4,688
| +2% | +$224K |
|
|
CDMO
3065
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $9.82M | ﹤0.01% |
794,861
+609,423
| +329% | +$6.98M |
|
3066
Viridian Therapeutics
VRDN
$2.49B
| $9.82M | ﹤0.01% |
512,071
+427,338
| +504% | +$9.29M |
|
|
LGF.B
3067
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $9.82M | ﹤0.01% |
1,300,134
+1,114,174
| +599% | +$7.81M |
|
3068
Brookfield Infrastructure
BIPC
$4.87B
| $9.81M | ﹤0.01% |
245,310
+96,331
| +65% | +$4.06M |
|
|
TPC
3069
Tutor Perini Cor
TPC
$5.04B
| $9.8M | ﹤0.01% |
405,156
+78,799
| +24% | +$2.14M |
|
3070
Cal-Maine
CALM
$3.98B
| $9.8M | ﹤0.01% |
95,208
+50,061
| +111% | +$4.72M |
|
3071
Avantis US Equity ETF
AVUS
$14.3B
| $9.8M | ﹤0.01% |
101,069
+5,859
| +6% | +$575K |
|
3072
CALL
Stryker
SYK
$129B
| $9.79M | ﹤0.01% |
27,200
+22,600
| +491% | +$8.37M |
|
3073
Vanguard Total Corporate Bond ETF
VTC
$1.72B
| $9.79M | ﹤0.01% |
129,328
+1,104
| +0.9% | +$85.2K |
|
3074
Gaotu Techedu
GOTU
$453M
| $9.78M | ﹤0.01% |
4,466,079
+4,281,251
| +2,316% | +$12.5M |
|
3075
VanEck Uranium + Nuclear Energy ETF
NLR
$4.04B
| $9.76M | ﹤0.01% |
120,038
+72,566
| +153% | +$6.49M |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.